NCT00026897View on ClinicalTrials.gov

Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 1997

Study Completion Date

December 31, 2002

Conditions
Neoplasm
Interventions
PROCEDURE

Gamma-camera imaging

PROCEDURE

Low-risk biopsy

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00026897 - Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer | Biotech Hunter | Biotech Hunter